PRESS RELEASE published on 01/30/2024 at 14:13, 9 months 24 days ago Zentek Announces Positive Therapeutic Results achieved by Triera Biosciences for C19HBA Zentek Ltd.'s subsidiary Triera Biosciences completes successful testing of C19HBA aptamer as therapeutic for SARS-CoV-2, outperforming monoclonal antibody in preclinical trials. C19HBA shows potential for prophylaxis and treatment. Future clinical trials and partnerships to be pursued Zentek Ltd. Triera Biosciences C19HBA Aptamer SARS-CoV-2 Therapeutic Preclinical Trials
PRESS RELEASE published on 01/22/2024 at 16:00, 10 months 1 day ago Zentek Completes Study Quantifying Energy and Emission Savings of ZenGUARD(TM)-Enhanced HVAC Filters Zentek Ltd. announces the completion of a new study showing significant energy and cost savings for commercial buildings adopting ZenGUARDTM Enhanced Air Filters. The study highlights the reduction of infection risk and the potential to reduce HVAC energy consumption and CO2 emissions. Find out more on Zentek's website. Zentek Ltd. ZenGUARDTM Enhanced Air Filters HVAC Energy Consumption CO2 Emissions Commercial Buildings
PRESS RELEASE published on 01/19/2024 at 14:45, 10 months 4 days ago Zentek Announces Eric Wallman Appointed as Chairman of the Board Zentek Ltd., an intellectual property development and commercialization company, announces the resignation of Dr. Francis Dubé as Chairman of the Board and the appointment of Mr. Eric Wallman as the new Chairman according to best practices in governance. The company continues to focus on research, development, and commercialization of novel products, including their patented technology platform, ZenGUARD™, known for its anti-microbial activity and increased filtration efficiency. Zentek Ltd. Intellectual Property Development Governance Best Practices ZenGUARD Technology Commercialization Company
PRESS RELEASE published on 12/13/2023 at 21:30, 11 months 9 days ago Zentek Launches Triera Biosciences Ltd.
PRESS RELEASE published on 12/08/2023 at 14:15, 11 months 15 days ago Zentek and 1Click Heating and Cooling Sign Distribution Agreement
PRESS RELEASE published on 12/01/2023 at 03:17, 11 months 22 days ago Zentek Announces Grant of Stock Options Zentek Ltd. announces the granting of 400,000 stock options to a director and officer, exercisable at $1.75 per share, with vesting schedule. Zentek focuses on patent technology for novel products Stock Options Patented Technology Zentek Ltd. Intellectual Property Zentek News
PRESS RELEASE published on 11/29/2023 at 16:00, 11 months 24 days ago Zentek Reports Successful Testing of Aptamer Against Omicron Covid-19 Variant
PRESS RELEASE published on 11/21/2023 at 14:20, 1 year ago Zentek Announces Update on the Albany Graphite Project
PRESS RELEASE published on 11/15/2023 at 14:15, 1 year ago Zentek Reports Improvements and Expansion of its Aptamer-Based Platform Technology
PRESS RELEASE published on 10/17/2023 at 15:10, 1 year 1 month ago Zentek Completes Return on Investment Analysis for Canadian Healthcare System
Published on 11/22/2024 at 23:55, 16 hours 47 minutes ago Boron One Announces Early Warrant Exercise Incentive Program
Published on 11/22/2024 at 23:30, 17 hours 12 minutes ago Electric Royalties Enters Into Definitive Agreement to Acquire 0.75% Gross Revenue Royalty on Producing Punitaqui Copper Mine in Chile
Published on 11/22/2024 at 23:05, 17 hours 37 minutes ago Nexa Resources Announces Closing Transaction of Pukaqaqa Project Sale to Olympic
Published on 11/22/2024 at 22:30, 18 hours 12 minutes ago Delaforce Energy Corp. Announces Acquisition of Bouchard Well Service Ltd.
Published on 11/22/2024 at 18:14, 22 hours 27 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/22/2024 at 17:53, 22 hours 48 minutes ago Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/22/2024 at 16:55, 23 hours 46 minutes ago EQS-Adhoc: Comment on withdrawn non-binding offer
Published on 11/21/2024 at 06:58, 2 days 9 hours ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 2 days 21 hours ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 2 days 22 hours ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 2 days 22 hours ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024